Intuitive Surgical (NASDAQ: ISRG) CEO reports new stock unit grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
INTUITIVE SURGICAL INC director and CEO David J. Rosa reported multiple equity compensation transactions dated February 26, 2026. He acquired 4,788 performance stock units originally granted on February 28, 2023 and 3,018 performance stock units originally granted on June 12, 2023, after performance criteria were certified as achieved. These performance units are scheduled to vest on February 28, 2026, subject to continued service.
Rosa also received a new grant of 13,441 restricted stock units dated February 26, 2026, which vest 25% per year over four years. In addition, 3,816 and 2,289 previously granted restricted stock units were exercised into common stock on a one-for-one basis, with 1,892 and 1,135 common shares respectively withheld at a price of 506.17 per share to cover statutory tax obligations. After these transactions, he directly owned 232,648 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
6,105 shares exercised/converted
Mixed
9 txns
Insider
Rosa David J.
Role
Chief Executive Officer (CEO)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Stock Units - 2-28-2023 | 4,788 | $0.00 | -- |
| Grant/Award | Performance Stock Units - 6-12-2023 | 3,018 | $0.00 | -- |
| Exercise | Restricted Stock Units - 2-26-2024 | 3,816 | $0.00 | -- |
| Exercise | Restricted Stock Units - 2-26-2025 | 2,289 | $0.00 | -- |
| Grant/Award | Restricted Stock Units - 2-26-2026 | 13,441 | $0.00 | -- |
| Exercise | Common Stock | 3,816 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,892 | $506.17 | $958K |
| Exercise | Common Stock | 2,289 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,135 | $506.17 | $575K |
Holdings After Transaction:
Performance Stock Units - 2-28-2023 — 14,363 shares (Direct);
Performance Stock Units - 6-12-2023 — 9,052 shares (Direct);
Restricted Stock Units - 2-26-2024 — 7,631 shares (Direct);
Restricted Stock Units - 2-26-2025 — 6,866 shares (Direct);
Restricted Stock Units - 2-26-2026 — 13,441 shares (Direct);
Common Stock — 233,386 shares (Direct)
Footnotes (1)
- RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Represents performance stock units ("PSUs") initially granted to the Reporting Person on June 12, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28. 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.
FAQ
What insider activity did ISRG CEO David J. Rosa report on this Form 4?
David J. Rosa reported multiple equity compensation transactions, mainly awards and vesting of stock units, plus related tax withholding. The activity included performance stock units, restricted stock units converting into common stock, and shares withheld to satisfy tax obligations, rather than open-market purchases or sales.
How many performance stock units did ISRG CEO David J. Rosa receive?
Rosa reported 4,788 performance stock units from a February 28, 2023 grant and 3,018 from a June 12, 2023 grant. The compensation committee determined that performance goals were achieved, and these units are scheduled to vest on February 28, 2026, assuming he continues serving the company.
What new restricted stock unit grant did ISRG’s CEO receive?
He received a new grant of 13,441 restricted stock units dated February 26, 2026. Each unit represents a contingent right to one share of Intuitive Surgical common stock, vesting 25% on the first anniversary of grant and annually thereafter over a four-year period, subject to continued service.